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Background/aim: Takayasu’s arteritis (TA) is a rare, large-vessel vasculitis of unknown etiology, affecting aortic arch, and its main
branches. Noninvasive imaging methods are frequently used in diagnosis and follow-up in Takayasu’s arteritis. Studies investigating
optimal timing of follow up imaging are rare. This study is aimed to investigate the radiologic changes in vascular involvements of
Takayasu’s arteritis patients one year after diagnosis.
Materials and methods: Database of our Vasculitis Center was analyzed retrospectively and 97 patients were included into the
study. Demographic, clinical, radiological, and therapeutic findings of patients were recorded. Patients with follow-up imaging
after approximately one year of diagnosis were recruited into further analysis. Radiological changes and the effect of different
immunosuppressive agents on vascular involvements were investigated.
Results: Mean age and disease duration of patients were 43.0 and 9.0 years. The most commonly used imaging methods/modalities for
the diagnosis of TA were computer tomography-angiography (CT-Ang) (58.8%), magnetic resonance-angiography (MR-Ang) (29.9%),
and doppler ultrasonography (11.3%). Subclavian and common carotid arteries were the most frequently involved vessels. Fifty-three
patients underwent follow-up imaging after one year of diagnosis and, in 64% of patients, same imaging method had been used. MRAng (62.3%) and CT-Ang (35.9%) were the most preferred follow-up imaging studies. Sixty-eight percent of patients had stable
vascular involvement, 28% had progression, and 4% had regression. No difference was found in radiological changes regarding patients
with usage of different immunosuppressive agents (P = 0.634). There was no association between the change in serum acute phase
reactants and radiological disease activity.
Conclusion: The most commonly used imaging modality for the diagnosis of TA was CT-Ang, whereas MR-Ang was the most
preferred for follow-up. Almost 30% of TA patients in our Vasculitis Center had progression at around one year concordant with
previous literature. A follow-up imaging at around one year of treatment seems feasible in management of TA.
Key words: Takayasu’s arteritis, computer tomography angiography, magnetic resonance angiography, doppler ultrasonography,
conventional angiography, positron-emission tomography

1. Introduction
Takayasu’s arteritis is a rare, large-vessel vasculitis of
unknown etiology, characterized by granulomatous
inflammation of the vessel wall [1]. It frequently involves
the aortic arch and its main branches, the ascending aorta,
the thoracic descending aorta, and the abdominal aorta
[1].
Noninvasive imaging methods such as magnetic
resonance-angiography,
computer
tomographyangiography,
Doppler
ultrasonography
and
18F-fluorodeoxyglucose positron emission tomography/
computed tomography (PET/CT) have replaced

conventional angiography for diagnosis and monitoring
of disease activity in TA [1]. These noninvasive imaging
methods are superior to conventional angiography
because they can detect both luminal changes and
early inflammatory signs of the vessel wall (thickening
of the vessel wall and mural inflammation) and late
complications (stenosis and aneurysm) [2]. However,
there is an uncertainty about which imaging method will
be chosen for diagnosis and follow-up of patients with
large vessel vasculitis.
The aim of this study is to evaluate the used imaging
modalities for diagnosis and follow-up of TA patients.
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2. Materials and methods
2.1. Study population
In the prospective database of the Hacettepe University
Vasculitis Research Center (HUVAC), 97 TA patients
meeting the 1990 modified American College of
Rheumatology (ACR) criteria [3] were registered by
the end of July 2017. In the second step, 53 TA patients
who had a follow-up imaging study approximately one
year after the diagnosis were enrolled in the subsequent
analysis.
2.2. Demographic and clinical features
Data about demographics, comorbidities, disease duration,
distribution of vascular involvement, laboratory, previous
and current medications were obtained from hospital
records. Clinical disease activity was characterized by new
vascular/ischemic signs or general symptoms occurrence,
or inflammatory laboratory markers elevation. Erythrocyte
sedimentation rate (ESR) (0-20 mm / h) and C-reactive
protein (CRP) levels (<1 mg/dL) were used as markers of
disease activity.
2.3. Imaging modalities
Type of imaging methods (Doppler US, MR-Ang, CTAng, conventional angiography and PET/CT) used for
diagnosis and to monitor the disease activity approximately
one year ( ± 3 months) after the diagnosis were obtained
from the hospital records. In addition, we have recorded
in detail the distribution of involved vascular areas in
radiological imaging (one reader exists). The angiographic
findings were divided into five groups as described by the
International Conference on Takayasu Arteritis in Tokyo
in 1994: type 1 involves the aortic arch branches; type 2a
involves the ascending aorta, arch and its branches; type
2b involves the ascending aorta, arch with its branches,
and the descending aorta; type 3 involves the thoracic
descending aorta, abdominal aorta, and/or renal arteries;
type 4 involves only the abdominal aorta and/or renal
arteries; type 5 is the combined features of type 2b and 4
[4].
2.4. Follow up of data regarding acute phase reactants
and radiologic evaluation
The change in acute phase reactants was described
according to their cut-off levels (i.e; ESR<20 mm/h, CRP
<1mg/dL). If the initial level was above but the follow-up
level was below the cut-off point, it was given as a decrease
in acute phase reactant level. If the initial level was lower
and the follow-up level was higher than the cut-off, it was
given as an increase. If both initial and follow-up levels
were higher or lower than the cut-off levels, then it was
given as no change in acute phase reactants.
Radiological disease activity was classified as stable
disease (absence of any worsening or improvement in
stenotic or dilatated vasculitic lesions), progression
(development of a new lesion: vessel wall thickening/

irregularity, stenosis, occlusion, aneurysm, and dilatation
or worsening of the preexisting stenosis or dilatation) and
regression (improvement of preexisting vasculitic lesions)
according to follow-up imaging studies.
2.5. Ethical considerations
The study protocol was approved by Institutional Ethics
Committee (20.02.2014/GO14/84-16).
2.6. Statistical analysis
Statistical analyses were performed using the SPSS software
version 22 (IBM Corp., Armonk, NY, USA). The variables
were investigated using visual (histograms, probability
plots) and analytical methods (Kolmogorov-Simirnov/
Shapiro-Wilk’s test) to determine whether or not they are
normally distributed. Descriptive analyses were presented
using means and standard deviations for normally
distributed variables, medians, and interquartile ranges for
the nonnormally distributed variables, frequencies for the
categorical variables. Chi-square test was used to analyze
categorical variables. In the comparisons between groups,
the paired-samples t-test was used for normally distributed
variables and the Wilcoxon for nonnormally distributed
variables. A P-value of less than 0.05 was considered to
show a statistically significant result.
3. Results
3.1. Demographic, clinical, and treatment data
We recruited ninety-seven TA patients (92.8% female). The
demographic and clinical characteristics of TA patients
were summarized in Table 1. None of the patients received
a biological agent for first-line therapy. Twenty-four
patients (24.7%) switched either to another conventional
immunosuppressive agent (n = 11) or to a biological agent
(n = 13). The most commonly used biological agents were
tocilizumab (n = 5), infliximab (n = 4), adalimumab (n =
2), and etanercept (n = 2), respectively.
3.2. Imaging modalities and angiographic characteristics
The imaging modalities performed for diagnosis of TA
were CT/CT angiography in 57 (58.8%) patients, MR
angiography in 29 (29.9%) patients, and Doppler US
examination in 11(11.3%) patients. (Table 2) In the initial
diagnosis, the most frequently affected vessels were left
subclavian artery (67.9%), left common carotid artery
(52.8%), right subclavian artery (47.2%), and aortic arch
(47.2%), respectively. (Table 3) According to the 1994
angiographic classification system, the most common
type of angiographic involvement at diagnosis was type
V (39.2%), followed by type I (26.8%), type IIb (16.5%),
type IIa (11.3%) and type IV (2.1%). Pulmonary arterial
involvement was similar in both right and left pulmonary
arteries (11.3%). Renal artery stenosis was detected in
20.8% of patients in the left renal artery and in 9.4% of
patients in the right renal artery (Table 3).
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Table 1. Demographic, laboratory, and treatment features of
patients with Takayasu’s arteritis (n = 97).
Female, (%) (n)

92.8% (90)

Age, years ϯ

43.0 ± 14.4

Age at diagnosis,years ϯ

34.7 ± 12.1

Disease duration, years ϯ

9.1 ± 5.2

Diagnosis delay time,months (median,IQR) 19.0 (36)
ESR (mm/h) ϯ

37.3 ± 28.6

CRP (mg/L) ϯ

31.0 ± 48.0

Hemoglobin (g/dL) ϯ

12.2 ± 1.6

Mean corpuscular volume ϯ (fL)

81.0 ± 7.5

White blood cell count ϯ (103/ mm3)

9.347 ± 3.800

Thrombocyte count ϯ (µL)

357.019 ± 110.940

Treatment features

ϯ

Corticosteroids, n (%)

97 (100%)

Methotrexate, n (%)

38 (39.2%)

Cyclophosphamide, n (%)

36 (37.1%)

Azatioprine, n (%)

21 (21.6)

Micophenolate mofetile, n (%)

2 (2.1)

Biological drugs, n (%)

13 (13.4%)

Values are mean ± standard deviation.

Table 2. Angiographical findings of TA patients at diagnosis.
Imaging modality

n(%)

CT- Ang

57 (58.8)

MR-Ang

29 (29.9)

Doppler US

11 (11.3)

PET-CT

0 (0)

Conventional angiography

0(0)

Lesion type

n(%)

Type 1

26 (26.8)

Type 2a

11 (11.3)

Type 2b

16 (16.5)

Type 3

4 ( 4.1)

Type 4

2 (2.1)

Type 5

38 (39.2)

3.3 Follow up of data regarding acute phase reactants and
radiologic evaluation
A follow-up imaging study was scheduled for 53 (n =
50 females) patients approximately one year after the
diagnosis. Imaging techniques used to assess disease
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Table 3. The frequencies of vascular involvements of TA patients.
Vascular involvement

(%)

Ascending aorta

37.7

Aortic arch

47.2

Descending Thoracic aorta

43.4

Abdominal aorta

45.3

Left subclavian

67.9

Left common carotid artery

52.8

Truncus brachiocephalicus

22.6

Right subclavian artery

47.2

Right common carotid artery

37.7

Right axillary artery

17.0

Left axillary artery

15.1

Right iliac artery

9.4

Left iliac artery

9.4

Right femoral artery

3.8

Left femoral artery

3.8

Right renal artery

9.4

Left renal artery

20.8

Right pulmonary artery

11.3

Left pulmonary artery

11.3

activity during follow-up were MR-Ang (62.3%), CT-Ang
(35.8%), and Doppler US (1.9%) (Table 4). In 34 of patients
(64%), initial diagnostic and follow-up imaging modalities
were the same. Follow-up studies showed radiologically
stable disease in 32 patients (60.4%), progression in 15
patients (28.3%), and regression in six patients (11.3%).
(Table 5) In six of 15 patients (40%) with radiological
progression, treatment was modified.
When the association between the radiological disease
activity and the change in acute phase reactants at the
time of follow-up was evaluated, no association was found
between the groups. (Table 5) At the time of follow-up
imaging, 71.2% of patients had normal ESR and CRP
levels even though these patients had elevated acute phase
reactants at diagnosis. In patients with radiologically
stable disease, five patients (15.6%) had elevated CRP
levels at the time of follow-up imaging although their
initial levels were within normal levels. Nine patients with
high baseline CRP were found to regress to normal limits
during follow-up imaging. In eight of 15 patients with
radiologic progression, the ESR and/or CRP levels were
found within normal levels. We did not find significant
association between initial treatments of patients and the
radiological disease activity status at follow-up. (Table 5)
When the changes in acute phase reactants at diagnosis
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Table 4. Imaging methods used at diagnosis and during followup of TA patients (n = 53).
Imaging method

Diagnosis n (%) Follow-up

n (%)

Conventional-ang

0 (0)

0 (0)

Doppler US

6 (11.3)

Doppler US 1 (16.7)
MR-ang
5 (83.8)

CT angiography

31 (58.5)

CT-ang
MR-ang

18 (58.1)
13 (41.9)

MR angiography

16 (30.2)

CT- ang
MR-ang

1 (6.2)
15 (93.8)

and approximately one year follow-up were evaluated,
we found a statistically significant decrease (P < 0.001).
The changes in acute phase reactants and hematological
parameters were summarized in Table 6.
4. Discussion
In recent years, imaging methods such as MR-Ang, CTAng, and PET/CT have become important in largevessel vasculitis [2]. These methods offer a more sensitive
and rapid noninvasive assessment of aorta, cranial,
and extracranial arteries compared to conventional
angiography [2]. Although these new imaging methods
have many advantages, there is an uncertainty about which

imaging method will be chosen for diagnosis and followup of patients. In this study, CT-angiography was the most
commonly used imaging methods for diagnosis, whereas
MR-Angiography was the most commonly used imaging
method for follow-up. The European League Against
Rheumatology (EULAR) 2018 guidelines on the imaging
of large vessel vasculitis suggested MR-Ang as the first-line
imaging modality for the diagnosis of TA due to the lack of
radiation exposure and it is reported as an expert’s opinion
that CT, PET, and/or US can also be used as alternative
imaging modalities [2].
In 1994, Takayasu’s arteritis was classified into five
groups according to angiographic findings [4]. In our
study, types V and I had the highest frequency followed by
types IIa, IIb, III and IV, respectively. A cohort by Ohigashi
et al. in Japan, in accordance with our study, reported the
highest frequency in type 5, followed by type 1, with the
lowest frequency in type 4 [5]. The study conducted by
Freitas et al. reported the highest frequency in types V and
I followed by types IV, III, IIa, and IIb, respectively [6]. In
TA, the subclavian artery is the most frequently involved
vessel and the left subclavian artery is more frequently
involved than the right [7]. The aorta, the main carotid
artery, the renal artery and the other primary branches
of the aorta have lower rates of involvement, respectively
[8]. In our patients, the left subclavian artery had the
highest frequency (67.9%) of involvement, followed by
left main carotid artery, right subclavian artery, aortic

Table 5. Association of change in acute phase reactants and initial treatment features of TA patients with radiological
disease activity status at follow-up (n = 53).
Radiologically
Stable,n(%)

Radiologically
Progression,n(%)

Radiologically
Regression,n(%)

Increase

2 (6.3)

1 (6.7)

1 (16.7)

Decrease

13 (40.6)

2 (13.3)

3 (50.0)

No change

17 (53.1)

12 (80.0)

2 (33.3)

Change in ESR ϯ

P value
0.177

Change in CRP ϯ

0.375

Increase

5 (15.6)

3 (20.0)

0 (0.0)

Decrease

9 (28.1)

6 (40.0)

4 (66.7)

No change

18 (56.3)

6 (40.0)

2 (33.3)

Initial treatment ϯ

0.614

CYC

11 (34.3)

6 (40.0)

2 (33.3)

MTX

12 (37.5)

6 (40.0)

4 (66.7)

AZA

8 (25.0)

3 (20.0)

0 (0.0)

MMF

1 (3.1)

0 (0.0)

0 (0.0)

AZA: Azatiopyrin; CYC: Cyclophosphamide; MMF: Mycophenolat mofetil; MTX: Methrotrexate.
ϯ
Chi-square test was used.
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Table 6. Laboratory features of TA patients at diagnosis and during control imaging (n = 53).
Diagnosis

Follow-up

P

ESR (mm/h), median (IQR)

39.5 (12.3-59.8)

15.5 (9.3-24)

<0.001

CRP (mg/L) , median (IQR)

1.61 (0.74-4.7)

0.64 (0.37-1.32)

<0.001

Hemoglobin (g/dL), mean (± SS)

12.2 ± 1.6

12.7 ± 1.7

0.066

MCV (fL) , mean (± SS)

81 ± 7.5

84.2 ± 7.5

<0.001

WBC (103/mm3) , median (IQR)

9100(7050-11100)

9000(6750-12200)

0.431

Thrombocyte count(µL), mean (± SS)

357019 ± 110940

329340 ± 78549

0.053

Hb: Hemoglobin; MCV: Mean corpuscular volume; SD: Standard deviation; WBC: White blood cell.
ϯ
Correlation between repeated measures were analyzed by Wilcoxon and paired-samples t test.

arch, abdominal aorta, and descending aorta, respectively.
Similarly, a cohort of 248 patients from Turkey showed
that the left subclavian artery had the highest frequency of
involvement (76.0%), followed by carotid arteries (52.0%)
[9]. However, Freitas et al. from Brasil reported the highest
frequency of involvement in the abdominal aorta, followed
by the left subclavian artery and the left main carotid
artery, respectively [6]. The difference in the involvement
of arterial lesions in different countries can be attributed to
the role of ethnic and genetic factors in the pathogenesis
of TA [5]. Pulmonary artery involvement in TA is seen up
to 50.0% of patients [10]. In the study of Sharma et al. with
44 TA patients, pulmonary artery involvement was seen
in 14.3% of patients [11]. In our study, though, we found
pulmonary artery involvement in 11.3% of the patients.
Renal artery involvement is reported to be seen in 8%38% of TA patients [12]. Renal artery involvement was
recorded in 20.8% of our patients in the left renal artery,
in 9.4% in the right renal artery, and, in 28.6% of them,
bilateral involvement was seen.
There is also uncertainty about the timing of follow-up
imaging studies to assess disease activity and the degree
of damage. Chatterjee et al. suggested that follow-up
imaging studies should be performed in the presence of
suspected relapse or at least annually in asymptomatic
disease [13]. The Cleveland Clinic Center for Vasculitis
Care and Research has been performing imaging for
follow-up of TA patients every 6 to 12 months in routine
practice since 1992 [14]. Tombetti and Mason stated that
response to treatment of TA is typically monitored by
MR-Ang or CT-Ang every 6-12 months for the first two
years, and once clinical remission is sustained, annual
monitoring by MR-Ang is recommended [15]. On the
other hand, 2018 EULAR guidelines stated that follow-up
imaging studies should be repeated in the presence of a
suspected exacerbation, but that imaging studies are not
required in cases with clinical or laboratory remission [2].
The frequency of imaging assessments was recommended
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to be decided on individual basis. Again, according to this
guideline, the type of imaging method for monitoring
disease activity in TA and Giant cell arteritis (GCA)
should be decided according to expertise and vessels
affected [2]. In our study, 53 patients (54.6%) were found
to have follow-up imaging studies approximately one year
after diagnosis, which was consistent with the literature.
MR-Ang (62.3%) and CT-Ang (35.9%) were the most
preferred follow-up imaging studies, respectively. There
are no standardized and reliable methods for monitoring
disease activity and evaluating the therapeutic response
in patients with TA. Acute phase proteins are not always
correlated with inflammatory activity in the vessel wall
[16]. Despite normal ESR and serum CRP levels, active
disease in the vessel wall can be detected by imaging
methods [14,17,18]. In the second step of our study, we
compared radiological disease activity and its correlation
with acute phase reactants according to a comparative
evaluation of baseline and control imaging studies. In
our study, the same imaging modality was used in 64%
of patients. Even though, 36% of patients had undergone
different imaging modalities for evaluation of vascular
involvement, as both MR-Ang and CT-Ang directly reflect
hemodynamic disturbance and the risk of end-organ
ischemia, comparable data can be obtained from these
two imaging modalities [19]. In the study of Tombetti et
al., similar to our study, baseline scans of 131 large vessel
vasculitis patients (96 TA, 35 LV-GCA) were 114 MR-ang
and 17 CT-Ang and 67 patients underwent additional
scan of MR-ang at median interval of 18 months [19].
Same approach was also used by Nakagomi et al. in order
to develop combined arteritis damage score where they
analyzed the angiographic data from CT and MR-Ang
of 41 TA and 55 GCA patients retrospectively [20]. In
our study, follow-up imaging evaluations showed stable
disease in 60.4%, progression in 28.3%, and regression
in 11.3% of patients. There was no significant association
between radiological findings and change in serum ESR
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and CRP levels (P = 0.177 and P = 0.375, respectively).
An increase in serum ESR levels were found in 6.3% of
patients with radiological stable disease (n = 2) and in 6.7%
of patients with radiological progressive disease (n = 1).
Also, an increase in serum CRP levels were found in 15.6%
of patients with radiological stable disease and in 20.0% of
patients with radiological progressive disease. In the study
of Tombetti, longitudinal MR-Ang of patients of a median
of 18 months revealed 40% stable vasculitic lesions, 37%
progression, and 23% improvement [19]. MaksimowiczMcKinnon showed normal levels of acute phase reactants
in 23% of TA patients with active disease [14]. While ESR
and CRP levels were normal in 46% of patients with newly
developed vascular involvement in MR angiography, there
was an increase in the levels of acute phase reactants in the
remaining patients despite no change in MR angiographic
examination findings [13].
Evaluating the disease activity of TA is still challenging.
[21] There is no standardized assessment of vascular
imaging modalities such as CT-Ang, MR-Ang, or PET/CT,
and also there is no accepted gold standard for describing
radiological assessment [15,18]. Previous studies
showed progression of vascular lesions and presence of
histologically active disease in half of patients despite
clinical and laboratory remission. On the other hand, TA is
generally slowly progressive disease and progression rate of
radiological findings are variable [22].
The major limitations of our study are as follows: due
to retrospective design of the study, disease activity indexes
such as Indian Takayasu Arteritis Activity Score (ITAS2010)

has not been calculated [23]. Also the data was based on
one reader report for each imaging; there is no intra/interobserver assessment for the radiologic evaluation.
Additionally, we had six patients diagnosed just with
Doppler US and no other modalities. Regarding these six
patients, it was difficult to evaluate thoracic, ascendant, and
descending aorta, pulmonary arteries, as well. Therefore,
convenience of initial classification with doppler US could
be limited.
In conclusion, there is no standard imaging method
(MR-Ang, CT-Ang, Doppler US, PET/CT) for assessing
disease activity and response to treatment. Although,
comparable angiographic data can be obtained from MRAng and CT-Ang, their features are different and these
imaging modalities cannot be accepted as equivalent as far
as inter-modality reproducibility is studied. Therefore, it is
usually recommended to use the same imaging technique
for both diagnosis and monitoring disease activity. Even
though, the data about the frequency of screening disease
activity is limited, it seems reasonable to screen patients
in whom a flare is suspected or annually in asymptomatic
patients.
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